← Leaderboards
Kelly Grimes
Cincinnati Childrens Hosp Med Ctr
$183,846
Attributed
$183,846
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $65.6K · FY2017–19$100K$75K$50K$25K$0
'17
'18
'19
Funding mix
By agency
NIH$183,846 · 1
By mechanism
F32$183,846 · 1
Top collaborators
No co-investigators on record.
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Jeffery D Molkentin$48,923,505
- Jennifer Michelle Davis$10,964,584
- Donald M Bers$56,507,614
- Catherine A Makarewich$3,231,838
- Katherine E Yutzey$22,408,688
Others in their field
Other Emerging Leaders on “Adaptor Signaling Protein”
- Tomohiro Nakamura · Scripps Research Institute, The$3,512,996
- Alexandra M. Deaconescu · Brown University$3,268,438
- Eunhee Choi · Columbia University Health Sciences$3,242,300
- Melike Lakadamyali · University Of Pennsylvania$2,935,693
- Patrycja Marta Dubielecka-Szczerba · Rhode Island Hospital$2,858,388
- Princess Izevbua Imoukhuede · Washington University$2,706,238
Research focus
Adaptor Signaling ProteinGrowthAffectAdenovirusesBindingAdultCardiacCardiac MyocytesCardiovascular DiseasesCategoriesCell GrowthCell NucleusCell ProliferationCellsCell TypeCytoplasmCytoskeletal ProteinsCytosolDilated CardiomyopathyDissociationDockingExhaustionExperimental StudyHeart
Grant awards (3)
Defining the mechanisms whereby MEK1/2 and ERK1/2 signaling control cardiomyocyte directional growth$65,606
F32 · FY2019 · HL · contact PI
Defining the mechanisms whereby MEK1/2 and ERK1/2 signaling control cardiomyocyte directional growth$61,174
F32 · FY2018 · HL · contact PI
Defining the mechanisms whereby MEK1/2 and ERK1/2 signaling control cardiomyocyte directional growth$57,066
F32 · FY2017 · HL · contact PI